Fasudil dihydrochloride

Synonyms: HA-1077 dihydrochloride; AT-877 dihydrochloride
Fasudil (HA-1077; AT877) dihydrochloride 是一种非特异性 RhoA/ROCK 抑制剂,同时抑制蛋白激酶,其对 ROCK1 的 Ki 为 0.33 μM,对 ROCK2、PKA、PKC、PKG 的 IC50 分别为 0.158 μM、4.58 μM、12.30 μM、1.650 μM,并且也是一种有效的 Ca2+ 通道拮抗剂和血管扩张剂。
产品编号: MS-L98216 纯度: 99.98% CAS No.: 203911-27-7 分子式: C14H19Cl2N3O2S 分子量: 364.29
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
3-5 天
200mg
询价
询价
500mg
询价
询价

产品描述

Fasudil (HA-1077; AT877) dihydrochloride 是一种非特异性 RhoA/ROCK 抑制剂,同时抑制蛋白激酶,其对 ROCK1 的 Ki 为 0.33 μM,对 ROCK2、PKA、PKC、PKG 的 IC50 分别为 0.158 μM、4.58 μM、12.30 μM、1.650 μM,并且也是一种有效的 Ca2+ 通道拮抗剂和血管扩张剂。

生物实验数据

生物活性 Fasudil (HA-1077; AT877) dihydrochloride is a non-specific RhoA/ROCK inhibitor that also inhibits protein kinases, with a Ki of 0.33 μM for ROCK1 and IC50 values of 0.158 μM, 4.58 μM, 12.30 μM, and 1.650 μM for ROCK2, PKA, PKC, and PKG, respectively, and it is also a potent Ca2+ channel antagonist and vasodilator.
IC50 & Target ROCK2:0.158 μM, PKA:4.58 μM, PKC:12.3 μM, ROCK1 (p160ROCK):0.33 μM (Ki), PKG:1.65 μM
体外研究
(In Vitro)

Fasudil dihydrochloride (100 μM) inhibits cell spreading, the formation of stress fibers, and expression of α-SMA with concomitant suppression of cell growth in rat HSCs (hepatic stellate cells) and human HSC-derived TWNT-4 cells.
Fasudil dihydrochloride (50-100 μM; 24 hours) inhibits the LPA (lysophoaphatidic acid)-induced phosphorylation of ERK1/2, JNK, and p38 detected by western blotting in rat HSCs and human HSC-derived TWNT-4 cells.
Fasudil dihydrochloride (25-100 μM; 24 hours) suppresses transcription of collagen and TIMP, stimulates transcription of MMP-1 in human HSC-derived TWNT-4 cells.

Western Blot Analysis

Cell Line: Rat HSCs and human HSC-derived TWNT-4 cells
Concentration: 50 μM; 100 μM
Incubation Time: 24 hours
Result: Suppressed the LPA-induced phosphorylation of ERK1/2, JNK and p38 MAPK by 60%, 70%,and 90%, respectively.

RT-PCR

Cell Line: Rat HSCs and human HSC-derived TWNT-4 cells
Concentration: 25 μM; 50 μM; 100 μM
Incubation Time: 24 hours
Result: Reduced the expression of type I collagen, a-SMA, and TIMP-1.
体内研究
(In Vivo)

Fasudil dihydrochloride (10 mg/kg; i.v.; 1 h before operation) exhibits protectable effects on cardiovascular disease and reduces the activation of JNK and attenuates mitochondrial-nuclear translocation of AIF under ischemic injury.
Fasudil dihydrochloride (50 mg/kg/d; i.p.) inhibits acute and relapsing EAE (experimental autoimmune encephalomyelitis) induced by proteolipid protein PLP p139-151, reduces lymphocytes proliferation, results downregulation of interleukin (IL)-17 and a marked decrease of the IFN-γ/IL-4 ratio.
Fasudil dihydrochloride (100 mg/kg/d; p.o.) significantly reduces incidence and pathological examination score of EAE (experimental autoimmune encephalomyelitis) in SJL/J mice, decreases inflammation, demyelination, axonal loss and APP positivein spinal cord in mice.

Animal Model: Myocardial ischemia and reperfusion in rat (250-300 g)
Dosage: 10 mg/kg
Administration: Intravenous injection; 1 h before operation
Result: Activated the Rho-kinase, JNK, and resulted AIF translocated to the nucleus.
Inhibited Rho-kinase activity, and reduced myocardial infarct size and heart cell apoptosis.
性状 固体
颜色 White to off-white

化学信息

分子量 364.29
分子式 C14H19Cl2N3O2S
CAS No. 203911-27-7
别名 HA-1077 dihydrochloride; AT-877 dihydrochloride

储存&溶解度

储存方式

4°C, sealed storage, away from moisture

*In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

H2O 中的溶解度 : ≥ 100 mg/mL (274.51 mM)

DMSO 中的溶解度 : 20.83 mg/mL (57.18 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

* "≥" means soluble, but saturation unknown.

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO / H2O1 mM2.7451 mL13.7253 mL27.4507 mL68.6266 mL
5 mM0.5490 mL2.7451 mL5.4901 mL13.7253 mL
10 mM0.2745 mL1.3725 mL2.7451 mL6.8627 mL
15 mM0.1830 mL0.9150 mL1.8300 mL4.5751 mL
20 mM0.1373 mL0.6863 mL1.3725 mL3.4313 mL
25 mM0.1098 mL0.5490 mL1.0980 mL2.7451 mL
30 mM0.0915 mL0.4575 mL0.9150 mL2.2876 mL
40 mM0.0686 mL0.3431 mL0.6863 mL1.7157 mL
50 mM0.0549 mL0.2745 mL0.5490 mL1.3725 mL
H2O60 mM0.0458 mL0.2288 mL0.4575 mL1.1438 mL
80 mM0.0343 mL0.1716 mL0.3431 mL0.8578 mL
100 mM0.0275 mL0.1373 mL0.2745 mL0.6863 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础